Navigation Links
Arena Pharmaceuticals Provides Update on GPR119 Portfolio for Type 2 Diabetes
Date:11/4/2010

119 is expressed in beta cells, which are located in the pancreas and responsible for producing insulin in response to increases in blood glucose. Stimulation of GPR119 has been shown to promote insulin release by beta cells in response to elevated blood glucose levels. In addition, GPR119 is expressed in cells other than pancreatic beta cells, such as endocrine cells in the gastrointestinal tract. In preclinical studies and clinical trials, GPR119 has been shown to stimulate the release of GLP-1, GIP and PYY, incretins that play important roles in insulin regulation and metabolism.

About Diabetes The International Diabetes Federation estimates that approximately 285 million adults worldwide will have diabetes in 2010, and that approximately 90-95% of diabetics in developed countries suffer from type 2 diabetes, which is characterized by inadequate response to insulin, inadequate secretion of insulin as blood glucose levels rise, or dysregulation of glucose production by the liver. Therapies for type 2 diabetes are directed toward correcting the body's inadequate response with oral or injectable medications, directly modifying insulin levels by injection of insulin or insulin analogs, modifying nutrient absorption from the gut or modifying hepatic glucose production.

A significant portion of type 2 diabetics fail oral medication and require injectable agents. Current oral medications for type 2 diabetes have a number of side effects, including hypoglycemia, weight gain, edema, and possibly an increase in cardiovascular mortality, prompting continued efforts to develop therapeutics to improve the treatment of diabetes.

About Arena PharmaceuticalsArena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors, an important class of validated drug targets, in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and met
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Endologix Announces Publication of Clinical Trial Results Supporting Anatomical Fixation with a Suprarenal Aortic Extension
2. Arena and Eisai Announce Upcoming Lorcaserin Presentations at Obesity 2010
3. Arena and Eisai Provide Update on Lorcaserin FDA Advisory Committee Meeting
4. Arena Pharmaceuticals to Host Conference Call and Webcast Following Lorcaserin FDA Advisory Committee Meeting
5. Arena Pharmaceuticals Submits New Drug Application to FDA for Lorcaserin for Weight Management
6. Published Data Demonstrate Arena Pharmaceuticals Lorcaserin Has Low Abuse Potential
7. Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments
8. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, November 10, 2009
9. Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009
10. Arena Pharmaceuticals Reports Positive, Highly Significant BLOSSOM Trial Results for Weight Management; NDA Submission on Track for December
11. Arena Pharmaceuticals to Host Conference Call and Webcast on Friday, September 18, 2009, to Discuss Results from the BLOSSOM Phase 3 Trial of Lorcaserin for Weight Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2015 The report "Silage Inoculants ... (Lactobacillus, Pediococcus & Enterococcus), Enzymes (Fibre-digesting & Starch-digesting), Crop-type ... Silage Inoculants & Enzymes Market is expected to reach ... from 2015 to 2020. Browse 75 ... 194 P ages and an in-depth ...
(Date:7/2/2015)... China , 2. Juli 2015 ... für DNA-Screening in Hongkong vom American College ... in Hongkong ist das erste klinische Next-Generation-Sequencing ... ein CAP-Zertifkat erhält und somit die ... zu den bestehenden US FDA - 21 ...
(Date:7/2/2015)... CHICAGO, Ill. , July 2, 2015  AbbVie ... financial results on Friday, July 24, 2015, before the ... webcast of the earnings conference call at 8 a.m. ... through AbbVie,s Investor Relations website at www.abbvieinvestor.com . ... after 11 a.m. Central time. About AbbVie ...
Breaking Medicine Technology:Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 4BGI erhält Akkreditierung vom College of American Pathologists (CAP) 2
(Date:7/2/2015)... , ... July 02, 2015 , ... Global leader and ... in compression socks designed for men. , For style that’s quick on its ... daily routine. This is great news for men everywhere because a simple change in ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... 2015” provides comprehensive information on the pipeline products with comparative analysis of ... wound therapy (NPWT) with 22 market data tables and 4 figures, spread ...
(Date:7/2/2015)... , ... July 02, 2015 , ... ... Tunnel treatment and wrist pain treatment. Dr. Lev Kalika, founder of New ... a leading international authority on the conservative treatment of back, hip, knee and ...
(Date:7/2/2015)... ... ... Hand sanitizers have become extremely popular with an annual industry growth rate ... and radio host Sharon Kleyne, hand sanitizers can effectively decrease the presence of disease ... must be applied correctly and users must be aware of its limitations. , ...
(Date:7/2/2015)... ... July 02, 2015 , ... The report summarizes ... manufacturers. The report is a valuable source of guidance and direction for companies ... Chinese market for the Gelatin Capsule industry including capacity, production, production value, cost ...
Breaking Medicine News(10 mins):Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 2Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 4Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 2Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 2Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 4
... on Inc. 5000 list ... and new members, DOVER, N.H., Aug. 25 ... Free" atmosphere and friendly prices, earned,the top spot among ... 5,000 fastest-growing private businesses in the United States., ...
... consulting with school staff on avoidance strategies , , MONDAY, ... staff need to take measures to ensure the safety ... food allergies, says the American Academy of Allergy, Asthma ... and school staff is a key ingredient to keeping ...
... Aug. 25 Researchers at Scripps Translational,Science Institute (STSI) ... of a gene responsible for the majority of inherited ... online Aug. 24 in,Nature., Neuroblastoma -- a cancer ... childhood cancer deaths and has bleak survival probabilities of,less ...
... Integrated EHR Leader,s Growth Up 47 Percent from ... Greenway Medical Technologies,Inc., further establishing itself as ... practice management and interoperability,solutions, recently announced a 47 ... ending June 30, 2008, as compared to fiscal ...
... General Assembly for Allowing Dependents Ages,19-26 to Get Covered ... The face of a,broken health care system keeps ... are now the largest segment of the population without,health ... to change that by allowing more people in their ...
... N.Y., Aug. 25 Reflecting the expanding,scope of ... social, cultural,and environmental factors on health care systems ... Mary Ann Liebert Inc. have renamed,the peer-reviewed journal ... name of the journal (formerly Disease Management) begins ...
Cached Medicine News:Health News:N.H.-Based Health Club Operator Sets The Industry's Pace 2Health News:Food Allergy Action Plan Can Keep Kids From Harm 2Health News:Scripps Translational Science Institute Contributes to Discovery of Predisposition Gene for Childhood Cancer 2Health News:Greenway Medical Technologies' Growth Continues with Significant Fiscal Year 2008 Gains 2Health News:Greenway Medical Technologies' Growth Continues with Significant Fiscal Year 2008 Gains 3Health News:Younger Adults in Illinois Aided by Expansion of Health Care Coverage 2Health News:Disease Management Journal Changes Name and Expands Focus to Population Health Management 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: